Commentary
Drotrecogin alfa (activated): does current evidence support treatment for any patients with severe sepsis?
-
* Corresponding author: Jan O Friedrich j.friedrich@utoronto.ca
Critical Care 2006, 10:145 doi:10.1186/cc4947
No comments have yet been made on this article.